ExodusPoint Capital Management, LP
Position in TMCI — Treace Medical Concepts, Inc.
CIK 1736225
NEW YORK, NY
Position in TMCI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$211,560
-$22,462 QoQ
Shares Held
53,156
+90.6% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 116 holders
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMCI Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $464,643,980 across 33 Medical Devices names. TMCI ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
1,090,430 | $344,303,272 | |
| 2 | BSX |
Boston Scientific Corp
|
504,948 | $21,551,180 | |
| 3 | LIVN |
LivaNova PLC
|
207,801 | $17,087,476 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
180,884 | $15,572,303 | |
| 5 | TNDM |
Tandem Diabetes Care Inc
|
691,789 | $10,439,096 | |
| 6 | ABT |
Abbott Laboratories
|
109,826 | $9,965,611 | |
| 7 | DXCM |
Dexcom Inc
|
116,548 | $7,849,507 | |
| 8 | BFLY |
Butterfly Network, Inc.
|
761,861 | $6,414,869 |
All Filings in TMCI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,560 | 53,156 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $234,022 | 27,893 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $250,884 | 33,721 | Shares | Sole | 2025-02-12 | |
| 2024-03-31 | $724,248 | 55,498 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $397,589 | 15,543 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $382,056 | 15,167 | Shares | Other | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||